Brookhaven Lab and BioSET, Inc., Patent a Synthetic Peptide That Enhances Bone Growth
Thursday, February 19, 2009
Brookhaven Science Associates, the company that operates and manages the U.S. Department of Energy’s Brookhaven National Laboratory (BNL), and Biosurface Engineering Technologies, Inc. (BioSET), have been issued a U.S. patent on a synthetic peptide, called B2A.